Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Acute Kidney Injury Due to Circulatory Failure

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

20 Active assets in the Acute Kidney Injury Due to Circulatory Failure cohort.

Asset / SponsorPhaseRating
Giapreza
The Cleveland Clinic
Phase 4BB
Everolimus
MARIO ABBUD FILHO
Phase 4B
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Tanta University
Phase 4B
NORMAL HUMAN SERUM ALBUMIN
Institute of Liver and Biliary Sciences, India
Phase 3B
Noradrenaline
University of California, Los Angeles
Phase 4B

View all 32 →

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →